End Stage Renal Disease Patients. Chronic kidney disease (CKD)
Conditions
Interventions
Intervention 1: Intervention group: 6 weeks of intervention using SpiroXpert, proprietary designed pitot tube, floXpert, Iran twice a week during dialysis. Intervention 2: Control group: Standard Trea
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Has A History Of At Least 3 Months Of Dialysis No Lung Cancer Or Other Terminal Tumors
Exclusion criteria
Exclusion criteria: Long-Term Use Of Continuous Positive Pressure Breathing Apparatus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary Function. Timepoint: Before and Immediately After The Intervention. Method of measurement: Spirometry.;Quality of Life. Timepoint: Before and Immediately After The Intervention. Method of measurement: Kidney disease quality of life; KDQOL-SFTM 1.3.;Sleep Quality. Timepoint: Before and Immediately After The Intervention. Method of measurement: Petersburg Sleep Quality Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSajad Hasanzadeh
Yasouj University of Medical Sciences
Outcome results
None listed